These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7966138

  • 21. Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.
    Bellier B, McCort-Tranchepain I, Ducos B, Danascimento S, Meudal H, Noble F, Garbay C, Roques BP.
    J Med Chem; 1997 Nov 21; 40(24):3947-56. PubMed ID: 9397175
    [Abstract] [Full Text] [Related]

  • 22. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
    Fossa AA, DePasquale MJ, Morrone J, Zorn SH, Bryce D, Lowe JA, McLean S.
    J Pharmacol Exp Ther; 1997 Apr 21; 281(1):180-7. PubMed ID: 9103496
    [Abstract] [Full Text] [Related]

  • 23. CCK-B receptor-mediated stimulation of polyphosphoinositide turnover in GH3 pituitary cells in response to cholecystokinin and pentagastrin.
    Smith AJ, Freedman SB.
    Life Sci; 1996 Apr 21; 58(11):883-95. PubMed ID: 8786694
    [Abstract] [Full Text] [Related]

  • 24. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
    Bellier B, Da Nascimento S, Meudal H, Gincel E, Roques BP, Garbay C.
    Bioorg Med Chem Lett; 1998 Jun 02; 8(11):1419-24. PubMed ID: 9871777
    [Abstract] [Full Text] [Related]

  • 25. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
    Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP.
    J Med Chem; 1993 Jan 08; 36(1):166-72. PubMed ID: 8421283
    [Abstract] [Full Text] [Related]

  • 26. 2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK(2) receptor antagonists.
    McDonald IM, Dunstone DJ, Kalindjian SB, Linney ID, Low CM, Pether MJ, Steel KI, Tozer MJ, Vinter JG.
    J Med Chem; 2000 Sep 21; 43(19):3518-29. PubMed ID: 11000006
    [Abstract] [Full Text] [Related]

  • 27. Structure-antigastrin activity relationships of new spiroglumide amido acid derivatives.
    Makovec F, Peris W, Frigerio S, Giovanetti R, Letari O, Mennuni L, Revel L.
    J Med Chem; 1996 Jan 05; 39(1):135-42. PubMed ID: 8568800
    [Abstract] [Full Text] [Related]

  • 28. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
    Singh L, Field MJ, Hill DR, Horwell DC, McKnight AT, Roberts E, Tang KW, Woodruff GN.
    Eur J Pharmacol; 1995 Nov 14; 286(2):185-91. PubMed ID: 8605955
    [Abstract] [Full Text] [Related]

  • 29. Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureas.
    Castro JL, Ball RG, Broughton HB, Russell MG, Rathbone D, Watt AP, Baker R, Chapman KL, Fletcher AE, Patel S, Smith AJ, Marshall GR, Ryecroft W, Matassa VG.
    J Med Chem; 1996 Feb 16; 39(4):842-9. PubMed ID: 8632408
    [Abstract] [Full Text] [Related]

  • 30. Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats.
    Lloyd KC, Raybould HE, Walsh JH.
    Am J Physiol; 1992 Sep 16; 263(3 Pt 1):G287-92. PubMed ID: 1357976
    [Abstract] [Full Text] [Related]

  • 31. A second generation of non-peptide cholecystokinin receptor antagonists and their possible therapeutic potential.
    Freedman SB, Patel S, Smith AJ, Chapman K, Fletcher A, Kemp JA, Marshall GR, Hargreaves RJ, Scholey K, Mellin EC.
    Ann N Y Acad Sci; 1994 Mar 23; 713():312-8. PubMed ID: 8185173
    [Abstract] [Full Text] [Related]

  • 32. Modification of "peptoid" CCK-B antagonists to probe requirements for CCK-B agonist activity.
    Davey AE, Horwell DC.
    Bioorg Med Chem; 1993 Jul 23; 1(1):45-58. PubMed ID: 8081837
    [Abstract] [Full Text] [Related]

  • 33. Species specificity of pharmacological characteristics of CCK-B receptors.
    Kuwahara T, Kudoh T, Nakano A, Yoshizaki H, Takamiya M, Nagase H, Arisawa M.
    Neurosci Lett; 1993 Aug 06; 158(1):1-4. PubMed ID: 8233061
    [Abstract] [Full Text] [Related]

  • 34. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.
    Boden PR, Higginbottom M, Hill DR, Horwell DC, Hughes J, Rees DC, Roberts E, Singh L, Suman-Chauhan N, Woodruff GN.
    J Med Chem; 1993 Mar 05; 36(5):552-65. PubMed ID: 7684452
    [Abstract] [Full Text] [Related]

  • 35. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 05; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

  • 36. RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat.
    Pendley CE, Fitzpatrick LR, Capolino AJ, Davis MA, Esterline NJ, Jakubowska A, Bertrand P, Guyon C, Dubroeucq MC, Martin GE.
    J Pharmacol Exp Ther; 1995 Jun 05; 273(3):1015-22. PubMed ID: 7791071
    [Abstract] [Full Text] [Related]

  • 37. Three-dimensional molecular shape analysis-quantitative structure-activity relationship of a series of cholecystokinin-A receptor antagonists.
    Tokarski JS, Hopfinger AJ.
    J Med Chem; 1994 Oct 14; 37(21):3639-54. PubMed ID: 7932591
    [Abstract] [Full Text] [Related]

  • 38. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
    J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851
    [Abstract] [Full Text] [Related]

  • 39. Development of 1,4-benzodiazepine cholecystokinin type B antagonists.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Garsky VM, Gilbert KF, Leighton JL, Carson KL, Mellin EC.
    J Med Chem; 1993 Dec 24; 36(26):4276-92. PubMed ID: 8277510
    [Abstract] [Full Text] [Related]

  • 40. Relationship between dihedral angles of N1 and C9 substituents in 1,4-benzodiazepines and dual cholecystokinin-A and -B antagonistic activities.
    Tabuchi S, Nakanishi I, Satoh Y.
    Bioorg Med Chem Lett; 1998 Jun 16; 8(12):1449-54. PubMed ID: 9873368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.